Coronary Endothelial Function Is Preserved With Chronic Endothelin Receptor Antagonism in Experimental Hypercholesterolemia in Vitro

Arteriosclerosis, Thrombosis, and Vascular Biology - United States
doi 10.1161/01.atv.19.11.2769
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Ovid Technologies (Wolters Kluwer Health)

Related search

Angiotensin II Type 1 Receptor Antagonism Improves Hypercholesterolemia-Associated Endothelial Dysfunction

Arteriosclerosis, Thrombosis, and Vascular Biology
Cardiovascular MedicineCardiology
2002English

Chronic Selective Endothelin a Receptor Antagonism Reduces Serum Uric Acid in Hypertensive Chronic Kidney Disease

Hypertension
Internal Medicine
2011English

Attenuated in Vitro Coronary Arteriolar Vasorelaxation to Insulin-Like Growth Factor I in Experimental Hypercholesterolemia

Hypertension
Internal Medicine
1999English

Leptin Induces Endothelin-1 in Endothelial Cells in Vitro

Circulation Research
Cardiovascular MedicinePhysiologyCardiology
2002English

Folic Acid in Endothelial Function in Familial Hypercholesterolemia Response

Circulation
Cardiovascular MedicinePhysiologyCardiology
2000English

Selective Loss of Microvascular Endothelial Function in Human Hypercholesterolemia

Circulation
Cardiovascular MedicinePhysiologyCardiology
1994English

Endothelin Receptor a Antagonism Attenuates Renal Medullary Blood Flow Impairment in Endotoxemic Pigs

PLoS ONE
Multidisciplinary
2011English

Arrestin(g) Podocyte Injury With Endothelin Antagonism

Journal of the American Society of Nephrology : JASN
MedicineNephrology
2013English

Endothelin Receptor Antagonism: A New Era in the Treatment of Pulmonary Arterial Hypertension

Advances in Pulmonary Hypertension
2002English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy